State of Wyoming Buys 17,499 Shares of Ardent Health Partners, LLC (NYSE:ARDT)

State of Wyoming grew its stake in Ardent Health Partners, LLC (NYSE:ARDT - Free Report) by 123.3% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 31,693 shares of the company's stock after purchasing an additional 17,499 shares during the period. State of Wyoming's holdings in Ardent Health Partners were worth $541,000 as of its most recent SEC filing.

Other institutional investors have also made changes to their positions in the company. JPMorgan Chase & Co. bought a new position in shares of Ardent Health Partners in the third quarter worth about $154,000. US Bancorp DE acquired a new position in Ardent Health Partners during the fourth quarter valued at approximately $31,000. Ventas Inc. acquired a new position in Ardent Health Partners during the fourth quarter valued at approximately $159,570,000. Barclays PLC grew its holdings in Ardent Health Partners by 24.7% during the fourth quarter. Barclays PLC now owns 26,177 shares of the company's stock valued at $447,000 after purchasing an additional 5,185 shares during the period. Finally, Oliver Luxxe Assets LLC acquired a new position in Ardent Health Partners during the fourth quarter valued at approximately $1,465,000.

Analyst Ratings Changes

ARDT has been the topic of a number of analyst reports. Guggenheim upped their price objective on Ardent Health Partners from $16.00 to $18.00 and gave the stock a "buy" rating in a research note on Friday, May 9th. Mizuho decreased their price target on Ardent Health Partners from $19.00 to $18.00 and set an "outperform" rating on the stock in a research report on Wednesday, April 9th. Royal Bank of Canada reissued an "outperform" rating and set a $21.00 target price on shares of Ardent Health Partners in a research note on Thursday, May 15th. Finally, Stephens reiterated an "overweight" rating and issued a $21.00 target price on shares of Ardent Health Partners in a report on Tuesday, May 20th. Two investment analysts have rated the stock with a hold rating, nine have issued a buy rating and two have assigned a strong buy rating to the company's stock. Based on data from MarketBeat.com, Ardent Health Partners has an average rating of "Buy" and a consensus target price of $20.67.

Ardent Health Partners Price Performance

Shares of NYSE ARDT traded down $0.19 during trading hours on Friday, reaching $14.61. 280,957 shares of the stock traded hands, compared to its average volume of 393,743. The company has a market capitalization of $2.09 billion and a P/E ratio of 8.96. The company has a quick ratio of 1.78, a current ratio of 1.91 and a debt-to-equity ratio of 0.78. Ardent Health Partners, LLC has a 52-week low of $11.31 and a 52-week high of $20.72. The company's 50-day simple moving average is $13.24 and its two-hundred day simple moving average is $14.74.

Ardent Health Partners (NYSE:ARDT - Get Free Report) last announced its quarterly earnings data on Tuesday, May 6th. The company reported $0.29 earnings per share for the quarter, beating analysts' consensus estimates of $0.21 by $0.08. The firm had revenue of $1.50 billion for the quarter, compared to analysts' expectations of $1.50 billion. Equities research analysts forecast that Ardent Health Partners, LLC will post 1.23 EPS for the current year.

Ardent Health Partners Company Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.